James Caldwell on The Hidden Culprit in Perimesencephalic SAH
James Caldwell, Interventional Neuroradiologist at Auckland City Hospital, shared on LinkedIn:
”When I went to school, I was taught that benign perimesencephalic subarachnoid hemorrhage (SAH) was most likely venous in origin—but the lack of direct evidence for a venous source always bothered me.
Later, I learned about basilar perforator aneurysms: “rare”, typically tiny aneurysms arising from basilar perforators that can present with SAH.
More recently, at our weekly neurovascular multidisciplinary meetings, we’ve repeatedly joked that “all” benign perimesencephalic hemorrhages are probably due to tiny or transient basilar perforator aneurysms that we never detect.
Well, some astute colleagues have shared a few compelling example cases at the page below – strongly recommend checking them out.
I read the page recently and it struck me like a chord.
What proportion of benign perimesencephalic SAH might be attributable to these lesions?
The page also highlights again what a valuable and deeply subspecialized resource neuroangio.org is.
Thank you to Maksim Shapiro et al!”
Find the full article here.

Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?